Ovarian cancer cells harboring mutations in the ARID1A tumor suppressor gene tend to use the amino acid glutamine as a source of energy more often, making the cells more vulnerable to compounds that interfere with glutamine metabolism, scientists found. As proof, they demonstrated that a compound that inactivates glutaminase (the enzyme that normally breaks down glutamine) can prevent tumor growth in mouse models of ovarian clear cell carcinomas (OCCC) whose cancer cells harbor ARID1A mutations.…
You must be logged in to read/download the full post.
The post Blocking Glutamine Metabolism May Help Combat OCCC Tumors appeared first on BioNewsFeeds.